Company intelligence
Execruit
Executive Search for Hard-to-Reach Biotech & Pharma Scientific, Commercial, & C-Suite Talent Across EU/US/APAC
About Execruit
Execruit is a Biopharma-focused executive and professional search firm built by industry insiders. Our team brings scientific depth and hands-on experience across R&D, commercial, and corporate development functions at leading global pharmaceutical companies giving us a working understanding of biopharma leadership that goes beyond traditional search. We advise boards and executive teams across the biopharmaceutical sector on senior leadership and critical talent appointments, leadership development, and CEO succession planning. Our core mandate is building high-impact teams for biotechs and pharmaceutical companies: identifying executives, functional leaders, and hard-to-find scientific talent who drive scientific innovation, clinical progress, and long-term commercial growth. We operate across multiple therapeutic areas with reach across the entire development life cycle from early discovery and IND-enabling research through global commercialisation and a clear view of the leadership shifts each stage demands. Our client base spans the full scale of the industry: from Series A and early-stage biotechs building their founding leadership teams, to publicly listed multinational pharmaceutical companies managing global executive succession. Across that range, we work directly with boards, founders, investors, executives, and hiring managers to place leaders who fit not just the role, but the science, strategy, and stage of the business. Leadership decisions in this industry shape pipelines, regulatory outcomes, and ultimately patient lives. Our work is built to reflect that delivering leaders equipped for long-term impact, not just candidates who meet a specification.
Verified activity
Signals from Execruit
5 published signals
People
Execruit noted that Sanofi's Paul Hudson was replaced by Belén Garijo after a restructuring push that didn't deliver fast enough.
Reported by Signe Reidla, MD, LL.B
People
Execruit noted that Kyowa Kirin named its first non-Japanese CEO.
Reported by Signe Reidla, MD, LL.B
People
Execruit noted that CSL's CEO departed abruptly this year amid a 40% share price drop and staff cuts.
Reported by Signe Reidla, MD, LL.B
People
Execruit noted that Vaxxas brought in a leader specifically to run commercialisation rather than early-stage R&D.
Reported by Signe Reidla, MD, LL.B
People
Execruit noted that Takeda's Julie Kim succeeded Christophe Weber, GSK's Luke Miles stepped in for Emma Walmsley, and Cipla named Achin Gupta.
Reported by Signe Reidla, MD, LL.B